{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:45:12Z","timestamp":1791488712382,"version":"4.3.4"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T00:00:00Z","timestamp":1416268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00281-014-0466-0","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T16:22:28Z","timestamp":1416586948000},"page":"187-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["The protective role of immunoglobulins in fungal infections and inflammation"],"prefix":"10.1007","volume":"37","author":[{"given":"Sri Ramulu","family":"Elluru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srini V.","family":"Kaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadeesh","family":"Bayry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,18]]},"reference":[{"key":"466_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nri1255","volume":"4","author":"L Romani","year":"2004","unstructured":"Romani L (2004) Immunity to fungal infections. Nat Rev Immunol 4:1\u201323","journal-title":"Nat Rev Immunol"},{"key":"466_CR2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nri2939","volume":"11","author":"L Romani","year":"2011","unstructured":"Romani L (2011) Immunity to fungal infections. Nat Rev Immunol 11:275\u2013288","journal-title":"Nat Rev Immunol"},{"key":"466_CR3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev-immunol-020711-074958","volume":"30","author":"M Wuthrich","year":"2012","unstructured":"Wuthrich M, Deepe GS Jr, Klein B (2012) Adaptive immunity to fungi. Annu Rev Immunol 30:115\u2013148","journal-title":"Annu Rev Immunol"},{"key":"466_CR4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.mib.2009.06.009","volume":"12","author":"B Hube","year":"2009","unstructured":"Hube B (2009) Fungal adaptation to the host environment. Curr Opin Microbiol 12:347\u2013349","journal-title":"Curr Opin Microbiol"},{"key":"466_CR5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.mib.2008.09.018","volume":"11","author":"NM Cooney","year":"2008","unstructured":"Cooney NM, Klein BS (2008) Fungal adaptation to the mammalian host: it is a new world, after all. Curr Opin Microbiol 11:511\u2013516","journal-title":"Curr Opin Microbiol"},{"key":"466_CR6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nature08264","volume":"460","author":"V Aimanianda","year":"2009","unstructured":"Aimanianda V, Bayry J, Bozza S et al (2009) Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 460:1117\u20131121","journal-title":"Nature"},{"key":"466_CR7","doi-asserted-by":"crossref","first-page":"e1002700","DOI":"10.1371\/journal.ppat.1002700","volume":"8","author":"J Bayry","year":"2012","unstructured":"Bayry J, Aimanianda V, Guijarro JI et al (2012) Hydrophobins\u2014unique fungal proteins. PLoS Pathog 8:e1002700","journal-title":"PLoS Pathog"},{"key":"466_CR8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1462-5822.2009.01318.x","volume":"11","author":"T Jouault","year":"2009","unstructured":"Jouault T, Sarazin A, Martinez-Esparza M et al (2009) Host responses to a versatile commensal: PAMPs and PRRs interplay leading to tolerance or infection by Candida albicans. Cell Microbiol 11:1007\u20131015","journal-title":"Cell Microbiol"},{"key":"466_CR9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.mib.2008.06.002","volume":"11","author":"FL Veerdonk van de","year":"2008","unstructured":"van de Veerdonk FL, Kullberg BJ, van der Meer JW et al (2008) Host-microbe interactions: innate pattern recognition of fungal pathogens. Curr Opin Microbiol 11:305\u2013312","journal-title":"Curr Opin Microbiol"},{"key":"466_CR10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.mib.2010.05.004","volume":"13","author":"C Bourgeois","year":"2010","unstructured":"Bourgeois C, Majer O, Frohner IE et al (2010) Fungal attacks on mammalian hosts: pathogen elimination requires sensing and tasting. Curr Opin Microbiol 13:401\u2013408","journal-title":"Curr Opin Microbiol"},{"key":"466_CR11","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1128\/IAI.70.10.5462-5470.2002","volume":"70","author":"C Bromuro","year":"2002","unstructured":"Bromuro C, Torosantucci A, Chiani P et al (2002) Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine. Infect Immun 70:5462\u20135470","journal-title":"Infect Immun"},{"key":"466_CR12","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1084\/jem.183.4.1905","volume":"183","author":"G Nussbaum","year":"1996","unstructured":"Nussbaum G, Yuan R, Casadevall A, Scharff MD (1996) Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans. J Exp Med 183:1905\u20131909","journal-title":"J Exp Med"},{"key":"466_CR13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/jlb.44.5.422","volume":"44","author":"U Kuruganti","year":"1988","unstructured":"Kuruganti U, Henderson LA, Garner RE et al (1988) Nonspecific and Candida-specific immune responses in mice suppressed by chronic administration of anti-mu. J Leukoc Biol 44:422\u2013433","journal-title":"J Leukoc Biol"},{"key":"466_CR14","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1128\/IAI.66.12.5771-5776.1998","volume":"66","author":"Y Han","year":"1998","unstructured":"Han Y, Morrison RP, Cutler JE (1998) A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect Immun 66:5771\u20135776","journal-title":"Infect Immun"},{"key":"466_CR15","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1128\/IAI.60.11.4534-4541.1992","volume":"60","author":"J Mukherjee","year":"1992","unstructured":"Mukherjee J, Scharff MD, Casadevall A (1992) Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun 60:4534\u20134541","journal-title":"Infect Immun"},{"key":"466_CR16","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/eji.200323790","volume":"33","author":"C Montagnoli","year":"2003","unstructured":"Montagnoli C, Bozza S, Bacci A et al (2003) A role for antibodies in the generation of memory antifungal immunity. Eur J Immunol 33:1193\u20131204","journal-title":"Eur J Immunol"},{"key":"466_CR17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.immunol.20.100301.064833","volume":"20","author":"R Berland","year":"2002","unstructured":"Berland R, Wortis HH (2002) Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20:253\u2013300","journal-title":"Annu Rev Immunol"},{"key":"466_CR18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0952-7915(95)80053-0","volume":"7","author":"A Coutinho","year":"1995","unstructured":"Coutinho A, Kazatchkine MD, Avrameas S (1995) Natural autoantibodies. Curr Opin Immunol 7:812\u2013818","journal-title":"Curr Opin Immunol"},{"key":"466_CR19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.coi.2006.07.010","volume":"18","author":"RR Hardy","year":"2006","unstructured":"Hardy RR (2006) B-1 B cells: development, selection, natural autoantibody and leukemia. Curr Opin Immunol 18:547\u2013555","journal-title":"Curr Opin Immunol"},{"key":"466_CR20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-3083.2003.01314.x","volume":"58","author":"H Kohler","year":"2003","unstructured":"Kohler H, Bayry J, Nicoletti A et al (2003) Natural autoantibodies as tools to predict the outcome of immune response? Scand J Immunol 58:285\u2013289","journal-title":"Scand J Immunol"},{"key":"466_CR21","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/srep02271","volume":"3","author":"ZH Zhou","year":"2013","unstructured":"Zhou ZH, Wild T, Xiong Y et al (2013) Polyreactive antibodies plus complement enhance the phagocytosis of cells made apoptotic by UV-light or HIV. Sci Rep 3:2271","journal-title":"Sci Rep"},{"key":"466_CR22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2004.02.004","volume":"25","author":"AL Notkins","year":"2004","unstructured":"Notkins AL (2004) Polyreactivity of antibody molecules. Trends Immunol 25:174\u2013179","journal-title":"Trends Immunol"},{"key":"466_CR23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nri2849","volume":"10","author":"MR Ehrenstein","year":"2010","unstructured":"Ehrenstein MR, Notley CA (2010) The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 10:778\u2013786","journal-title":"Nat Rev Immunol"},{"key":"466_CR24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1462-5822.2006.00786.x","volume":"9","author":"W Li","year":"2007","unstructured":"Li W, Fu M, An JG et al (2007) Host defence against C. albicans infections in IgH transgenic mice with V(H) derived from a natural anti-keratin antibody. Cell Microbiol 9:306\u2013315","journal-title":"Cell Microbiol"},{"key":"466_CR25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4049\/jimmunol.1102107","volume":"188","author":"SV Kaveri","year":"2012","unstructured":"Kaveri SV, Silverman GJ, Bayry J (2012) Natural IgM in immune equilibrium and harnessing their therapeutic potential. J Immunol 188:939\u2013945","journal-title":"J Immunol"},{"key":"466_CR26","doi-asserted-by":"crossref","first-page":"e60779","DOI":"10.1371\/journal.pone.0060779","volume":"8","author":"R Tian","year":"2013","unstructured":"Tian R, Fu M, Zhang Z et al (2013) In situ IgM production and clonal expansion of B-1 cells in peritoneal cavity promote elimination of C. albicans infection in IgH transgenic mice with VH derived from a natural antibody. PLoS One 8:e60779","journal-title":"PLoS One"},{"key":"466_CR27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0167-5699(97)84662-2","volume":"18","author":"A Cassone","year":"1997","unstructured":"Cassone A, Conti S, De Bernardis F et al (1997) Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature? Immunol Today 18:164\u2013169","journal-title":"Immunol Today"},{"key":"466_CR28","first-page":"472","volume":"2","author":"R Matthews","year":"2001","unstructured":"Matthews R, Burnie J (2001) Antifungal antibodies: a new approach to the treatment of systemic candidiasis. Curr Opin Investig Drugs 2:472\u2013476","journal-title":"Curr Opin Investig Drugs"},{"key":"466_CR29","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1128\/IAI.70.10.5790-5799.2002","volume":"70","author":"KL Wozniak","year":"2002","unstructured":"Wozniak KL, Wormley FL Jr, Fidel PL Jr (2002) Candida-specific antibodies during experimental vaginal candidiasis in mice. Infect Immun 70:5790\u20135799","journal-title":"Infect Immun"},{"key":"466_CR30","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.4049\/jimmunol.0901638","volume":"184","author":"KS Subramaniam","year":"2010","unstructured":"Subramaniam KS, Datta K, Quintero E et al (2010) The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol 184:5755\u20135767","journal-title":"J Immunol"},{"key":"466_CR31","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1084\/jem.20100034","volume":"207","author":"RR Rapaka","year":"2010","unstructured":"Rapaka RR, Ricks DM, Alcorn JF et al (2010) Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J Exp Med 207:2907\u20132919","journal-title":"J Exp Med"},{"key":"466_CR32","doi-asserted-by":"crossref","unstructured":"Szymczak WA, Davis MJ, Lundy SK et al. (2013) X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection. mBio 4: e00265-13","DOI":"10.1128\/mBio.00265-13"},{"key":"466_CR33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00436540","volume":"91","author":"PK Maiti","year":"1985","unstructured":"Maiti PK, Kumar A, Kumar R et al (1985) Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice. Mycopathologia 91:79\u201385","journal-title":"Mycopathologia"},{"key":"466_CR34","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/infdis\/164.5.936","volume":"164","author":"MT Cantorna","year":"1991","unstructured":"Cantorna MT, Balish E (1991) Acquired immunity to systemic candidiasis in immunodeficient mice. J Infect Dis 164:936\u2013943","journal-title":"J Infect Dis"},{"key":"466_CR35","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/IAI.59.6.2116-2119.1991","volume":"59","author":"R Narayanan","year":"1991","unstructured":"Narayanan R, Joyce WA, Greenfield RA (1991) Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect Immun 59:2116\u20132119","journal-title":"Infect Immun"},{"key":"466_CR36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0090-1229(84)90308-8","volume":"33","author":"EW Carrow","year":"1984","unstructured":"Carrow EW, Hector RF, Domer JE (1984) Immunodeficient CBA\/N mice respond effectively to Candida albicans. Clin Immunol Immunopathol 33:371\u2013380","journal-title":"Clin Immunol Immunopathol"},{"key":"466_CR37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/infdis\/174.3.589","volume":"174","author":"RD Wagner","year":"1996","unstructured":"Wagner RD, Vazquez-Torres A, Jones-Carson J et al (1996) B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis. J Infect Dis 174:589\u2013597","journal-title":"J Infect Dis"},{"key":"466_CR38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","volume":"11","author":"A Casadevall","year":"2012","unstructured":"Casadevall A, Pirofski LA (2012) Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe 11:447\u2013456","journal-title":"Cell Host Microbe"},{"key":"466_CR39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1084\/jem.192.4.475","volume":"192","author":"V Moulin","year":"2000","unstructured":"Moulin V, Andris F, Thielemans K et al (2000) B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med 192:475\u2013482","journal-title":"J Exp Med"},{"key":"466_CR40","doi-asserted-by":"crossref","first-page":"14210","DOI":"10.1073\/pnas.0402183101","volume":"101","author":"J Bayry","year":"2004","unstructured":"Bayry J, Lacroix-Desmazes S, Donkova-Petrini V et al (2004) Natural antibodies sustain differentiation and maturation of human dendritic cells. Proc Natl Acad Sci U S A 101:14210\u201314215","journal-title":"Proc Natl Acad Sci U S A"},{"key":"466_CR41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.175.1.15","volume":"175","author":"J Bayry","year":"2005","unstructured":"Bayry J, Lacroix-Desmazes S, Kazatchkine MD et al (2005) Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol 175:15\u201320","journal-title":"J Immunol"},{"key":"466_CR42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/blood-2011-06-360768","volume":"119","author":"A Morva","year":"2012","unstructured":"Morva A, Lemoine S, Achour A et al (2012) Maturation and function of human dendritic cells are regulated by B lymphocytes. Blood 119:106\u2013114","journal-title":"Blood"},{"key":"466_CR43","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1182\/blood-2012-02-408948","volume":"119","author":"MS Maddur","year":"2012","unstructured":"Maddur MS, Kaveri SV, Bayry J (2012) Regulation of human dendritic cells by B cells depends on the signals they receive. Blood 119:3863\u20133864","journal-title":"Blood"},{"key":"466_CR44","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1002\/art.34599","volume":"64","author":"O Berggren","year":"2012","unstructured":"Berggren O, Hagberg N, Weber G et al (2012) B lymphocytes enhance interferon-alpha production by plasmacytoid dendritic cells. Arthritis Rheum 64:3409\u20133419","journal-title":"Arthritis Rheum"},{"key":"466_CR45","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/art.38004","volume":"65","author":"MS Maddur","year":"2013","unstructured":"Maddur MS, Kaveri SV, Bayry J (2013) Dual role of CpG-stimulated B cells in the regulation of dendritic cells. Arthritis Rheum 65:2215\u20132216","journal-title":"Arthritis Rheum"},{"key":"466_CR46","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1038\/ncomms5092","volume":"5","author":"MS Maddur","year":"2014","unstructured":"Maddur MS, Sharma M, Hegde P, Stephen-Victor E, Pulendran B, Kaveri SV et al (2014) Human B cells induce dendritic cell maturation and favor Th2 polarization by inducing OX-40 ligand. Nat Commun 5:4092","journal-title":"Nat Commun"},{"key":"466_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11046-013-9671-y","volume":"176","author":"FS Tristao","year":"2013","unstructured":"Tristao FS, Panagio LA, Rocha FA et al (2013) B cell-deficient mice display enhanced susceptibility to Paracoccidioides brasiliensis infection. Mycopathologia 176:1\u201310","journal-title":"Mycopathologia"},{"key":"466_CR48","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1073\/pnas.0803195105","volume":"105","author":"H Xin","year":"2008","unstructured":"Xin H, Dziadek S, Bundle DR et al (2008) Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci U S A 105:13526\u201313531","journal-title":"Proc Natl Acad Sci U S A"},{"key":"466_CR49","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/CVI.05215-11","volume":"18","author":"H Xin","year":"2011","unstructured":"Xin H, Cutler JE (2011) Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis. Clin Vaccine Immunol 18:1656\u20131667","journal-title":"Clin Vaccine Immunol"},{"key":"466_CR50","doi-asserted-by":"crossref","first-page":"e35106","DOI":"10.1371\/journal.pone.0035106","volume":"7","author":"H Xin","year":"2012","unstructured":"Xin H, Cartmell J, Bailey JJ et al (2012) Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis. PLoS One 7:e35106","journal-title":"PLoS One"},{"key":"466_CR51","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20050749","volume":"202","author":"A Torosantucci","year":"2005","unstructured":"Torosantucci A, Bromuro C, Chiani P et al (2005) A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 202:597\u2013606","journal-title":"J Exp Med"},{"key":"466_CR52","doi-asserted-by":"crossref","first-page":"e5392","DOI":"10.1371\/journal.pone.0005392","volume":"4","author":"A Torosantucci","year":"2009","unstructured":"Torosantucci A, Chiani P, Bromuro C et al (2009) Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS One 4:e5392","journal-title":"PLoS One"},{"key":"466_CR53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1574-695X.2011.00802.x","volume":"62","author":"S Sandini","year":"2011","unstructured":"Sandini S, La Valle R, Deaglio S et al (2011) A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine. FEMS Immunol Med Microbiol 62:215\u2013224","journal-title":"FEMS Immunol Med Microbiol"},{"key":"466_CR54","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","volume":"30","author":"F Bernardis De","year":"2012","unstructured":"De Bernardis F, Amacker M, Arancia S et al (2012) A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models. Vaccine 30:4490\u20134498","journal-title":"Vaccine"},{"key":"466_CR55","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0264-410X(98)80113-8","volume":"16","author":"SA Theus","year":"1998","unstructured":"Theus SA, Smulian AG, Steele P et al (1998) Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response. Vaccine 16:1149\u20131157","journal-title":"Vaccine"},{"key":"466_CR56","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1172\/JCI26306","volume":"115","author":"M Zheng","year":"2005","unstructured":"Zheng M, Ramsay AJ, Robichaux MB et al (2005) CD4+ T cell-independent DNA vaccination against opportunistic infections. J Clin Invest 115:3536\u20133544","journal-title":"J Clin Invest"},{"key":"466_CR57","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI13826","volume":"108","author":"M Zheng","year":"2001","unstructured":"Zheng M, Shellito JE, Marrero L et al (2001) CD4+ T cell-independent vaccination against Pneumocystis carinii in mice. J Clin Invest 108:1469\u20131474","journal-title":"J Clin Invest"},{"key":"466_CR58","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1128\/IAI.69.5.3410-3412.2001","volume":"69","author":"AL Rosas","year":"2001","unstructured":"Rosas AL, Nosanchuk JD, Casadevall A (2001) Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection. Infect Immun 69:3410\u20133412","journal-title":"Infect Immun"},{"key":"466_CR59","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1128\/IAI.55.3.749-752.1987","volume":"55","author":"F Dromer","year":"1987","unstructured":"Dromer F, Charreire J, Contrepois A et al (1987) Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun 55:749\u2013752","journal-title":"Infect Immun"},{"key":"466_CR60","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1128\/CVI.00202-07","volume":"14","author":"ML Rodrigues","year":"2007","unstructured":"Rodrigues ML, Shi L, Barreto-Bergter E et al (2007) Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection. Clin Vaccine Immunol 14:1372\u20131376","journal-title":"Clin Vaccine Immunol"},{"key":"466_CR61","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","volume":"75","author":"A Rachini","year":"2007","unstructured":"Rachini A, Pietrella D, Lupo P et al (2007) An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect Immun 75:5085\u20135094","journal-title":"Infect Immun"},{"key":"466_CR62","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.4049\/jimmunol.154.4.1810","volume":"154","author":"R Yuan","year":"1995","unstructured":"Yuan R, Casadevall A, Spira G et al (1995) Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J Immunol 154:1810\u20131816","journal-title":"J Immunol"},{"key":"466_CR63","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/IAI.66.3.1057-1062.1998","volume":"66","author":"RR Yuan","year":"1998","unstructured":"Yuan RR, Spira G, Oh J et al (1998) Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice. Infect Immun 66:1057\u20131062","journal-title":"Infect Immun"},{"key":"466_CR64","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1128\/IAI.69.10.6445-6455.2001","volume":"69","author":"DO Beenhouwer","year":"2001","unstructured":"Beenhouwer DO, Shapiro S, Feldmesser M et al (2001) Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect Immun 69:6445\u20136455","journal-title":"Infect Immun"},{"key":"466_CR65","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.4049\/jimmunol.168.7.3419","volume":"168","author":"J Rivera","year":"2002","unstructured":"Rivera J, Mukherjee J, Weiss LM et al (2002) Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide. J Immunol 168:3419\u20133427","journal-title":"J Immunol"},{"key":"466_CR66","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1172\/JCI38322","volume":"120","author":"EE McClelland","year":"2010","unstructured":"McClelland EE, Nicola AM, Prados-Rosales R et al (2010) Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. J Clin Invest 120:1355\u20131361","journal-title":"J Clin Invest"},{"key":"466_CR67","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/IAI.70.5.2598-2604.2002","volume":"70","author":"S Shapiro","year":"2002","unstructured":"Shapiro S, Beenhouwer DO, Feldmesser M et al (2002) Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infect Immun 70:2598\u20132604","journal-title":"Infect Immun"},{"key":"466_CR68","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.4049\/jimmunol.174.12.8017","volume":"174","author":"J Rivera","year":"2005","unstructured":"Rivera J, Casadevall A (2005) Mouse genetic background is a major determinant of isotype-related differences for antibody-mediated protective efficacy against Cryptococcus neoformans. J Immunol 174:8017\u20138026","journal-title":"J Immunol"},{"key":"466_CR69","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1084\/jem.185.4.685","volume":"185","author":"G Nussbaum","year":"1997","unstructured":"Nussbaum G, Cleare W, Casadevall A et al (1997) Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J Exp Med 185:685\u2013694","journal-title":"J Exp Med"},{"key":"466_CR70","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1128\/IAI.63.7.2714-2719.1995","volume":"63","author":"Y Han","year":"1995","unstructured":"Han Y, Cutler JE (1995) Antibody response that protects against disseminated candidiasis. Infect Immun 63:2714\u20132719","journal-title":"Infect Immun"},{"key":"466_CR71","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1086\/516455","volume":"175","author":"Y Han","year":"1997","unstructured":"Han Y, Cutler JE (1997) Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J Infect Dis 175:1169\u20131175","journal-title":"J Infect Dis"},{"key":"466_CR72","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/IAI.68.3.1649-1654.2000","volume":"68","author":"Y Han","year":"2000","unstructured":"Han Y, Riesselman MH, Cutler JE (2000) Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect Immun 68:1649\u20131654","journal-title":"Infect Immun"},{"key":"466_CR73","doi-asserted-by":"crossref","first-page":"18078","DOI":"10.1074\/jbc.M112.355578","volume":"287","author":"MA Johnson","year":"2012","unstructured":"Johnson MA, Cartmell J, Weisser NE et al (2012) Molecular recognition of Candida albicans (1\u20132)-beta-mannan oligosaccharides by a protective monoclonal antibody reveals the immunodominance of internal saccharide residues. J Biol Chem 287:18078\u201318090","journal-title":"J Biol Chem"},{"key":"466_CR74","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.intimp.2010.08.027","volume":"10","author":"Y Han","year":"2010","unstructured":"Han Y (2010) Efficacy of combination immunotherapy of IgM MAb B6.1 and amphotericin B against disseminated candidiasis. Int Immunopharmacol 10:1526\u20131531","journal-title":"Int Immunopharmacol"},{"key":"466_CR75","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.4049\/jimmunol.167.3.1550","volume":"167","author":"Y Han","year":"2001","unstructured":"Han Y, Kozel TR, Zhang MX et al (2001) Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J Immunol 167:1550\u20131557","journal-title":"J Immunol"},{"key":"466_CR76","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1128\/IAI.65.12.5354-5357.1997","volume":"65","author":"TC Caesar-TonThat","year":"1997","unstructured":"Caesar-TonThat TC, Cutler JE (1997) A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity. Infect Immun 65:5354\u20135357","journal-title":"Infect Immun"},{"key":"466_CR77","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1128\/IAI.71.9.5273-5279.2003","volume":"71","author":"MD Moragues","year":"2003","unstructured":"Moragues MD, Omaetxebarria MJ, Elguezabal N et al (2003) A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities. Infect Immun 71:5273\u20135279","journal-title":"Infect Immun"},{"key":"466_CR78","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1128\/AAC.00892-10","volume":"55","author":"S Brena","year":"2011","unstructured":"Brena S, Cabezas-Olcoz J, Moragues MD et al (2011) Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans. Antimicrob Agents Chemother 55:3156\u20133163","journal-title":"Antimicrob Agents Chemother"},{"key":"466_CR79","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1128\/CDLI.12.9.1063-1068.2005","volume":"12","author":"AK Chaturvedi","year":"2005","unstructured":"Chaturvedi AK, Kavishwar A, Shiva Keshava GB et al (2005) Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosis. Clin Diag Lab Immunol 12:1063\u20131068","journal-title":"Clin Diag Lab Immunol"},{"key":"466_CR80","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1439-0507.2008.01635.x","volume":"52","author":"AK Chaturvedi","year":"2009","unstructured":"Chaturvedi AK, Kumar R, Kumar A et al (2009) A monoclonal IgM directed against immunodominant catalase B of cell wall of Aspergillus fumigatus exerts anti-A. fumigatus activities. Mycoses 52:524\u2013533","journal-title":"Mycoses"},{"key":"466_CR81","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1128\/AAC.01267-09","volume":"54","author":"E Appel","year":"2010","unstructured":"Appel E, Vallon-Eberhard A, Rabinkov A et al (2010) Therapy of murine pulmonary aspergillosis with antibody-alliinase conjugates and alliin. Antimicrob Agents Chemother 54:898\u2013906","journal-title":"Antimicrob Agents Chemother"},{"key":"466_CR82","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1128\/IAI.00349-08","volume":"76","author":"R Buissa-Filho","year":"2008","unstructured":"Buissa-Filho R, Puccia R, Marques AF et al (2008) The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB\/c mice challenged intratracheally with the fungus. Infect Immun 76:3321\u20133328","journal-title":"Infect Immun"},{"key":"466_CR83","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/IAI.70.3.1069-1074.2002","volume":"70","author":"F Gigliotti","year":"2002","unstructured":"Gigliotti F, Haidaris CG, Wright TW et al (2002) Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia. Infect Immun 70:1069\u20131074","journal-title":"Infect Immun"},{"key":"466_CR84","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/IAI.74.1.390-393.2006","volume":"74","author":"J Wells","year":"2006","unstructured":"Wells J, Haidaris CG, Wright TW et al (2006) Complement and Fc function are required for optimal antibody prophylaxis against Pneumocystis carinii pneumonia. Infect Immun 74:390\u2013393","journal-title":"Infect Immun"},{"key":"466_CR85","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI19361","volume":"112","author":"JD Nosanchuk","year":"2003","unstructured":"Nosanchuk JD, Steenbergen JN, Shi L et al (2003) Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest 112:1164\u20131175","journal-title":"J Clin Invest"},{"key":"466_CR86","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1128\/EC.00036-08","volume":"7","author":"L Shi","year":"2008","unstructured":"Shi L, Albuquerque PC, Lazar-Molnar E et al (2008) A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophages. Eukaryot Cell 7:1109\u20131117","journal-title":"Eukaryot Cell"},{"key":"466_CR87","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1128\/IAI.01443-08","volume":"77","author":"AJ Guimaraes","year":"2009","unstructured":"Guimaraes AJ, Frases S, Gomez FJ et al (2009) Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum. Infect Immun 77:1357\u20131367","journal-title":"Infect Immun"},{"key":"466_CR88","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1128\/IAI.65.9.3822-3827.1997","volume":"65","author":"MX Zhang","year":"1997","unstructured":"Zhang MX, Lupan DM, Kozel TR (1997) Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans. Infect Immun 65:3822\u20133827","journal-title":"Infect Immun"},{"key":"466_CR89","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/IAI.72.1.209-218.2004","volume":"72","author":"TR Kozel","year":"2004","unstructured":"Kozel TR, MacGill RS, Percival A et al (2004) Biological activities of naturally occurring antibodies reactive with Candida albicans mannan. Infect Immun 72:209\u2013218","journal-title":"Infect Immun"},{"key":"466_CR90","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/IAI.74.1.362-369.2006","volume":"74","author":"MX Zhang","year":"2006","unstructured":"Zhang MX, Bohlman MC, Itatani C et al (2006) Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice. Infect Immun 74:362\u2013369","journal-title":"Infect Immun"},{"key":"466_CR91","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molimm.2008.10.008","volume":"46","author":"GM Boxx","year":"2009","unstructured":"Boxx GM, Nishiya CT, Kozel TR et al (2009) Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans. Mol Immunol 46:473\u2013480","journal-title":"Mol Immunol"},{"key":"466_CR92","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.riam.2011.07.004","volume":"29","author":"R Calcedo","year":"2012","unstructured":"Calcedo R, Ramirez-Garcia A, Abad A et al (2012) Phosphoglycerate kinase and fructose bisphosphate aldolase of Candida albicans as new antigens recognized by human salivary IgA. Rev Iberoam Micol 29:172\u2013174","journal-title":"Rev Iberoam Micol"},{"key":"466_CR93","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00277-006-0129-x","volume":"85","author":"WJ Velden van der","year":"2006","unstructured":"van der Velden WJ, Blijlevens NM, Klont RR et al (2006) Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder. Ann Hematol 85:621\u2013623","journal-title":"Ann Hematol"},{"key":"466_CR94","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/bmt.2008.303","volume":"43","author":"L Gil","year":"2009","unstructured":"Gil L, Kozlowska-Skrzypczak M, Mol A et al (2009) Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT. Bone Marrow Transplant 43:121\u2013126","journal-title":"Bone Marrow Transplant"},{"key":"466_CR95","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1542\/peds.107.5.e66","volume":"107","author":"DL Goldman","year":"2001","unstructured":"Goldman DL, Khine H, Abadi J et al (2001) Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 107:E66","journal-title":"Pediatrics"},{"issue":"M110","key":"466_CR96","first-page":"004010","volume":"10","author":"A Pitarch","year":"2011","unstructured":"Pitarch A, Nombela C, Gil C (2011) Prediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serum. Mol Cell Proteomics 10(M110):004010","journal-title":"Mol Cell Proteomics"},{"key":"466_CR97","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-1097(04)00042-4","volume":"232","author":"A Viudes","year":"2004","unstructured":"Viudes A, Lazzell A, Perea S et al (2004) The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis. FEMS Microbiol Lett 232:133\u2013138","journal-title":"FEMS Microbiol Lett"},{"key":"466_CR98","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1128\/IAI.68.12.7049-7060.2000","volume":"68","author":"ML Rodrigues","year":"2000","unstructured":"Rodrigues ML, Travassos LR, Miranda KR et al (2000) Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. Infect Immun 68:7049\u20137060","journal-title":"Infect Immun"},{"key":"466_CR99","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/515688","volume":"178","author":"R Fleuridor","year":"1998","unstructured":"Fleuridor R, Zhong Z, Pirofski L (1998) A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosis. J Infect Dis 178:1213\u20131216","journal-title":"J Infect Dis"},{"key":"466_CR100","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","volume":"49","author":"RA Larsen","year":"2005","unstructured":"Larsen RA, Pappas PG, Perfect J et al (2005) Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis. Antimicrob Agents Chemother 49:952\u2013958","journal-title":"Antimicrob Agents Chemother"},{"key":"466_CR101","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/AAC.42.6.1437","volume":"42","author":"A Casadevall","year":"1998","unstructured":"Casadevall A, Cleare W, Feldmesser M et al (1998) Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother 42:1437\u20131446","journal-title":"Antimicrob Agents Chemother"},{"key":"466_CR102","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(84)91618-0","volume":"2","author":"RC Matthews","year":"1984","unstructured":"Matthews RC, Burnie JP, Tabaqchali S (1984) Immunoblot analysis of the serological response in systemic candidosis. Lancet 2:1415\u20131418","journal-title":"Lancet"},{"key":"466_CR103","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/JCM.25.2.230-237.1987","volume":"25","author":"RC Matthews","year":"1987","unstructured":"Matthews RC, Burnie JP, Tabaqchali S (1987) Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol 25:230\u2013237","journal-title":"J Clin Microbiol"},{"key":"466_CR104","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1128\/IAI.63.11.4506-4514.1995","volume":"63","author":"RK Swoboda","year":"1995","unstructured":"Swoboda RK, Bertram G, Budge S et al (1995) Structure and regulation of the HSP90 gene from the pathogenic fungus Candida albicans. Infect Immun 63:4506\u20134514","journal-title":"Infect Immun"},{"key":"466_CR105","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.vaccine.2003.11.032","volume":"22","author":"RC Matthews","year":"2004","unstructured":"Matthews RC, Burnie JP (2004) Recombinant antibodies: a natural partner in combinatorial antifungal therapy. Vaccine 22:865\u2013871","journal-title":"Vaccine"},{"key":"466_CR106","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","volume":"42","author":"J Pachl","year":"2006","unstructured":"Pachl J, Svoboda P, Jacobs F et al (2006) A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. Clin Infect Dis 42:1404\u20131413","journal-title":"Clin Infect Dis"},{"key":"466_CR107","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/jac\/dkn075","volume":"61","author":"S Hodgetts","year":"2008","unstructured":"Hodgetts S, Nooney L, Al-Akeel R et al (2008) Efungumab and caspofungin: pre-clinical data supporting synergy. J Antimicrob Chemother 61:1132\u20131139","journal-title":"J Antimicrob Chemother"},{"key":"466_CR108","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1128\/AAC.00435-12","volume":"56","author":"DL Richie","year":"2012","unstructured":"Richie DL, Ghannoum MA, Isham N et al (2012) Nonspecific effect of Mycograb on amphotericin B MIC. Antimicrob Agents Chemother 56:3963\u20133964","journal-title":"Antimicrob Agents Chemother"},{"key":"466_CR109","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-3148.2002.00360.x","volume":"12","author":"I Krause","year":"2002","unstructured":"Krause I, Wu R, Sherer Y et al (2002) In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations\u2014a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transfus Med 12:133\u2013139","journal-title":"Transfus Med"},{"key":"466_CR110","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"MD Kazatchkine","year":"2001","unstructured":"Kazatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747\u2013755","journal-title":"N Engl J Med"},{"key":"466_CR111","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2011.04387.x","volume":"164","author":"SV Kaveri","year":"2011","unstructured":"Kaveri SV, Maddur MS, Hegde P et al (2011) Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy. Clin Exp Immunol 164:2\u20135","journal-title":"Clin Exp Immunol"},{"key":"466_CR112","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10875-007-9088-9","volume":"27","author":"VS Negi","year":"2007","unstructured":"Negi VS, Elluru S, Siberil S et al (2007) Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol 27:233\u2013245","journal-title":"J Clin Immunol"},{"key":"466_CR113","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrrheum.2011.61","volume":"7","author":"J Bayry","year":"2011","unstructured":"Bayry J, Negi VS, Kaveri SV (2011) Intravenous immunoglobulin therapy in rheumatic diseases. Nat Rev Rheumatol 7:349\u2013359","journal-title":"Nat Rev Rheumatol"},{"key":"466_CR114","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","volume":"291","author":"MC Dalakas","year":"2004","unstructured":"Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 291:2367\u20132375","journal-title":"JAMA"},{"key":"466_CR115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2008.04.001","volume":"7","author":"U Nussinovitch","year":"2008","unstructured":"Nussinovitch U, Shoenfeld Y (2008) Intravenous immunoglobulin\u2014indications and mechanisms in cardiovascular diseases. Autoimmun Rev 7:445\u2013452","journal-title":"Autoimmun Rev"},{"key":"466_CR116","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0091-6749(91)90420-S","volume":"87","author":"BD Mazer","year":"1991","unstructured":"Mazer BD, Gelfand EW (1991) An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J Allergy Clin Immunol 87:976\u2013983","journal-title":"J Allergy Clin Immunol"},{"key":"466_CR117","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0091-6749(99)70466-5","volume":"103","author":"JD Spahn","year":"1999","unstructured":"Spahn JD, Leung DY, Chan MT et al (1999) Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin. J Allergy Clin Immunol 103:421\u2013426","journal-title":"J Allergy Clin Immunol"},{"key":"466_CR118","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/clim.1999.4714","volume":"91","author":"JL Kishiyama","year":"1999","unstructured":"Kishiyama JL, Valacer D, Cunningham-Rundles C et al (1999) A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol 91:126\u2013133","journal-title":"Clin Immunol"},{"key":"466_CR119","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0091-6749(99)70424-0","volume":"103","author":"LM Salmun","year":"1999","unstructured":"Salmun LM, Barlan I, Wolf HM et al (1999) Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial. J Allergy Clin Immunol 103:810\u2013815","journal-title":"J Allergy Clin Immunol"},{"key":"466_CR120","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/j.1468-3083.2011.04326.x","volume":"26","author":"F Toledo","year":"2012","unstructured":"Toledo F, Silvestre JF, Munoz C (2012) Combined therapy with low-dose omalizumab and intravenous immunoglobulin for severe atopic dermatitis. Report of four cases. J Eur Acad Dermatol Venereol 26:1325\u20131327","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"466_CR121","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1525-1470.2011.01654.x","volume":"29","author":"PJ Turner","year":"2012","unstructured":"Turner PJ, Kakakios A, Wong LC et al (2012) Intravenous immunoglobulin to treat severe atopic dermatitis in children: a case series. Pediatr Dermatol 29:177\u2013181","journal-title":"Pediatr Dermatol"},{"key":"466_CR122","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1365-2222.2010.03663.x","volume":"41","author":"GN Kaufman","year":"2011","unstructured":"Kaufman GN, Massoud AH, Audusseau S et al (2011) Intravenous immunoglobulin attenuates airway hyperresponsiveness in a murine model of allergic asthma. Clin Exp Allergy 41:718\u2013728","journal-title":"Clin Exp Allergy"},{"key":"466_CR123","doi-asserted-by":"crossref","unstructured":"Massoud AH, Guay J, Shalaby KH et al (2012) Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3-positive regulatory T cells. J Allergy Clin Immunol 129:1656-1665","DOI":"10.1016\/j.jaci.2012.02.050"},{"key":"466_CR124","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.4049\/jimmunol.1003076","volume":"186","author":"LM Araujo","year":"2011","unstructured":"Araujo LM, Chauvineau A, Zhu R et al (2011) Cutting edge: intravenous Ig inhibits invariant NKT cell-mediated allergic airway inflammation through FcgammaRIIIA-dependent mechanisms. J Immunol 186:3289\u20133293","journal-title":"J Immunol"},{"key":"466_CR125","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1016\/j.vaccine.2012.06.049","volume":"30","author":"T Batard","year":"2012","unstructured":"Batard T, Zimmer A, Nony E et al (2012) Anti-inflammatory activity of sublingual immunoglobulin (SLIG) in a murine model of allergen-driven airway inflammation. Vaccine 30:5666\u20135674","journal-title":"Vaccine"},{"key":"466_CR126","doi-asserted-by":"crossref","unstructured":"Massoud AH, Yona M, Xue D et al (2014) Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells. J Allergy Clin Immunol 133:853-863","DOI":"10.1016\/j.jaci.2013.09.029"},{"key":"466_CR127","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","volume":"313","author":"Y Kaneko","year":"2006","unstructured":"Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313:670\u2013673","journal-title":"Science"},{"key":"466_CR128","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.it.2008.08.004","volume":"29","author":"T Tha-In","year":"2008","unstructured":"Tha-In T, Bayry J, Metselaar HJ et al (2008) Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol 29:608\u2013615","journal-title":"Trends Immunol"},{"key":"466_CR129","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood-2002-05-1447","volume":"101","author":"J Bayry","year":"2003","unstructured":"Bayry J, Lacroix-Desmazes S, Carbonneil C et al (2003) Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 101:758\u2013765","journal-title":"Blood"},{"key":"466_CR130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2008.04.012","volume":"7","author":"JF Seite","year":"2008","unstructured":"Seite JF, Shoenfeld Y, Youinou P et al (2008) What is the contents of the magic draft IVIg? Autoimmun Rev 7:435\u2013439","journal-title":"Autoimmun Rev"},{"key":"466_CR131","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","volume":"127","author":"M Ballow","year":"2011","unstructured":"Ballow M (2011) The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 127:315\u2013323","journal-title":"J Allergy Clin Immunol"},{"key":"466_CR132","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.autrev.2011.02.007","volume":"10","author":"MS Maddur","year":"2011","unstructured":"Maddur MS, Kaveri SV, Bayry J (2011) Comparison of different IVIg preparations on IL-17 production by human Th17 cells. Autoimmun Rev 10:809\u2013810","journal-title":"Autoimmun Rev"},{"key":"466_CR133","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.autrev.2011.08.004","volume":"11","author":"MS Maddur","year":"2011","unstructured":"Maddur MS, Hegde P, Sharma M et al (2011) B cells are resistant to immunomodulation by \u2018IVIg-educated\u2019 dendritic cells. Autoimmun Rev 11:154\u2013156","journal-title":"Autoimmun Rev"},{"key":"466_CR134","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood-2009-06-225417","volume":"115","author":"E Aubin","year":"2010","unstructured":"Aubin E, Lemieux R, Bazin R (2010) Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation. Blood 115:1727\u20131734","journal-title":"Blood"},{"key":"466_CR135","doi-asserted-by":"crossref","unstructured":"Maddur MS, Vani J, Hegde P et al (2011) Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin. J Allergy Clin Immunol 127:823-830","DOI":"10.1016\/j.jaci.2010.12.1102"},{"key":"466_CR136","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.4049\/jimmunol.1201965","volume":"190","author":"S Othy","year":"2013","unstructured":"Othy S, Hegde P, Topcu S et al (2013) Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis. J Immunol 190:4535\u20134541","journal-title":"J Immunol"},{"key":"466_CR137","doi-asserted-by":"crossref","first-page":"e1002071","DOI":"10.1371\/journal.ppat.1002071","volume":"7","author":"C Ramakrishna","year":"2011","unstructured":"Ramakrishna C, Newo AN, Shen YW et al (2011) Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis. PLoS Pathog 7:e1002071","journal-title":"PLoS Pathog"},{"key":"466_CR138","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood-2012-11-468264","volume":"122","author":"J Trinath","year":"2013","unstructured":"Trinath J, Hegde P, Sharma M et al (2013) Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells. Blood 122:1419\u20131427","journal-title":"Blood"},{"key":"466_CR139","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","volume":"13","author":"I Schwab","year":"2013","unstructured":"Schwab I, Nimmerjahn F (2013) Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol 13:176\u2013189","journal-title":"Nat Rev Immunol"},{"issue":"181\u2013188","key":"466_CR140","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/j.jaci.2013.08.042","volume":"133","author":"JF Seite","year":"2014","unstructured":"Seite JF, Goutsmedt C, Youinou P et al (2014) Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells. J Allergy Clin Immunol 133(181\u2013188):e181\u2013e189","journal-title":"J Allergy Clin Immunol"},{"key":"466_CR141","doi-asserted-by":"crossref","first-page":"e26469","DOI":"10.1371\/journal.pone.0026469","volume":"6","author":"S Casulli","year":"2011","unstructured":"Casulli S, Topcu S, Fattoum L et al (2011) A differential concentration-dependent effect of IVIg on neutrophil functions: relevance for anti-microbial and anti-inflammatory mechanisms. PLoS One 6:e26469","journal-title":"PLoS One"},{"key":"466_CR142","doi-asserted-by":"crossref","first-page":"e31357","DOI":"10.1371\/journal.pone.0031357","volume":"7","author":"JW Semple","year":"2012","unstructured":"Semple JW, Kim M, Hou J et al (2012) Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) production. PLoS One 7:e31357","journal-title":"PLoS One"},{"key":"466_CR143","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jaci.2007.01.023","volume":"119","author":"S Gunten von","year":"2007","unstructured":"von Gunten S, Vogel M, Schaub A et al (2007) Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies. J Allergy Clin Immunol 119:1005\u20131011","journal-title":"J Allergy Clin Immunol"},{"key":"466_CR144","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/thx.52.7.662","volume":"52","author":"B Vrugt","year":"1997","unstructured":"Vrugt B, Wilson S, van Velzen E et al (1997) Effects of high dose intravenous immunoglobulin in two severe corticosteroid insensitive asthmatic patients. Thorax 52:662\u2013664","journal-title":"Thorax"},{"key":"466_CR145","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1398-9995.1994.tb00833.x","volume":"49","author":"T Jakobsson","year":"1994","unstructured":"Jakobsson T, Croner S, Kjellman NI et al (1994) Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma. Allergy 49:413\u2013420","journal-title":"Allergy"},{"key":"466_CR146","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1378\/chest.114.5.1349","volume":"114","author":"LP Landwehr","year":"1998","unstructured":"Landwehr LP, Jeppson JD, Katlan MG et al (1998) Benefits of high-dose i.v. immunoglobulin in patients with severe steroid-dependent asthma. Chest 114:1349\u20131356","journal-title":"Chest"},{"key":"466_CR147","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3899\/jrheum.110087","volume":"38","author":"A Pashov","year":"2011","unstructured":"Pashov A, Delignat S, Bayry J et al (2011) Enhancement of the affinity of glucocorticoid receptors as a mechanism underlying the steroid-sparing effect of intravenous immunoglobulin. J Rheumatol 38:2275","journal-title":"J Rheumatol"},{"key":"466_CR148","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nbt0297-155","volume":"15","author":"W Magliani","year":"1997","unstructured":"Magliani W, Conti S, de Bernardis et al (1997) Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat Biotechnol 15:155\u2013158","journal-title":"Nat Biotechnol"},{"key":"466_CR149","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1128\/IAI.71.11.6205-6212.2003","volume":"71","author":"L Polonelli","year":"2003","unstructured":"Polonelli L, Magliani W, Conti S et al (2003) Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis. Infect Immun 71:6205\u20136212","journal-title":"Infect Immun"},{"key":"466_CR150","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/IAI.70.5.2375-2382.2002","volume":"70","author":"E Cenci","year":"2002","unstructured":"Cenci E, Mencacci A, Spreca A et al (2002) Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation. Infect Immun 70:2375\u20132382","journal-title":"Infect Immun"},{"key":"466_CR151","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.4049\/jimmunol.156.5.1880","volume":"156","author":"L Polonelli","year":"1996","unstructured":"Polonelli L, De Bernadis F, Conti S et al (1996) Human natural yeast killer toxin-like candidacidal antibodies. J Immunol 156:1880\u20131885","journal-title":"J Immunol"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-014-0466-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-014-0466-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-014-0466-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T11:59:52Z","timestamp":1689681592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-014-0466-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,18]]},"references-count":151,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1007\/s00281-014-0466-0","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,18]]}}}